GenomCare

GenomCare GenomCare is a leading SME company involved in finding a potential cure for human genetic and infect

27/12/2022

Ferring Receives Approval from U.S. FDA for Adstiladrin for High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Ferring Receives Approval from U.S. FDA for Adstiladrin for High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer 16 December 2022 celia By celia 16 December 2022 0 Sha...

20/09/2022

The U.S. Food and Drug Administration (FDA) has approved Bluebird bio's gene therapy for the treatment of a rare neurological disorder, the company said late on Friday.

06/09/2022

The Investor Relations website contains information about bluebird bio, Inc.'s business for stockholders, potential investors, and financial analysts.

25/08/2022

Novartis has acknowledged that two patients have died of acute liver failure following treatment with its Zolgensma® (onasemnogene abeparvovec-xioi), a one-time gene therapy indicated for some forms of spinal muscular atrophy (SMA).

01/07/2022

Zolgensma gene therapy halts disease progression when given before the onset of symptoms to infants genetically diagnosed with SMA.

26/06/2022

First gene therapy to treat severe haemophilia A

02/06/2022

The CAR-T cell treatment is approved for adult patients who have had two or more previous therapies

01/06/2022

In mouse studies, pain-blocking neurotransmitters produced long-lasting benefits without detectable side effects. An international team of researchers led by scientists at the University of California San Diego School of Medicine reported that a gene therapy that inhibits targeted nerve cell signal

28/05/2022

The US Food and Drug Administration’s (FDA) top biologics regulator said the use of a  “playbook” or platform approach for developing multiple cell and gene therapy products and a globally harmonized template would facilitate the development of such proudcts at a 17 May meeting of the America...

27/05/2022

The May issue of The Advocate is out now! In this issue: A new ASGCT/ Congressional Policy Fellowship, Policy Summit agenda topics, & more! https://bit.ly/2QnF7mv

25/05/2022

The former NIH director and the president’s acting science advisor challenged gene therapy researchers and industry partners to do more to help deliver the benefits of gene therapy and gene editing to the largest number of patients in a keynote address at ASGCT.

Address

PINARBAŞI MAH. HÜRRİYET Caddesi AKDENİZ ÜNİ. ANTALYA TEKNOKENT AR-GE 2 ULUĞBEY 3 A B5 KONYAALTI
Antalya
07070

Website

Alerts

Be the first to know and let us send you an email when GenomCare posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to GenomCare:

Shortcuts

Share

Category